|Articles|March 1, 1996

Current Strategies in the Treatment of Cardiovascular Diseases: The Role of Beta-Blocker Therapy
Volume 2
Issue 5 Suppl

Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?

Author(s)Finn Waagstein, MD, PhD

Download PDF: Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?

Articles in this issue

over 30 years ago

Article

Introduction

over 30 years ago

Article

Utilization of Beta-Blockers: A First-Line Therapy in Hypertension

over 30 years ago

Article

Dispelling the Myths: Treatment of Patients with Ischemic Heart Disease and Left Ventricular Dysfunction

over 30 years ago

Article

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Orthopedic surgeon holds bone x-ray | Image Credit: © tippapatt - stock.adobe.com

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

ByHannah I. Travers, MD,Mikhail Kuznetsov, MD,John Mazzocco, MD,Nicholas Pagani, MD,Tricia Ide, DNP, RN,Brian L. Hollenbeck, MD,Eric L. Smith, MD

June 3rd 2026

Social Needs Screening and Supplemental Benefits in Medicare Advantage

ByJessica I. Billig, MD, MSc,Michael D. Dang, MS,Jennifer R. Cardin, MSc,Joseph H. Joo, MD, MS,Joshua M. Liao, MD, MSc

June 3rd 2026

Availability of Hospital Financial Assistance Documents in Non-English Languages

ByNina Linh Nguyen, MHA,Samantha Randall, BA,Ella Cho,Erin Trish, PhD,Erin L. Duffy, PhD, MPH

June 3rd 2026

Man having heart attack | Image Credit: © dragonstock - stock.adobe.com

Experts Sound Alarm on Underrecognized Heart Failure Subtype as Costs, Readmissions Soar

ByChristina Mattina

June 2nd 2026

Doctor and patient with obesity | Image Credit: © Studio Romantic - stock.adobe.com

Clinicians Grapple With Barriers to Multidisciplinary Obesity Treatment

ByChristina Mattina

June 2nd 2026

Sympathetic Modulation in Congestive Heart Failure: Where Do Beta-Blockers Stand?

Articles in this issue

Related Content

Musculoskeletal Quality Collaborative Improves Value-Based Health Care Delivery Across Hospital System

Social Needs Screening and Supplemental Benefits in Medicare Advantage

Availability of Hospital Financial Assistance Documents in Non-English Languages

Experts Sound Alarm on Underrecognized Heart Failure Subtype as Costs, Readmissions Soar

Clinicians Grapple With Barriers to Multidisciplinary Obesity Treatment

Trending on AJMC

FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301

New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease

Cancer’s Hidden Wound: Trauma From Diagnosis Through Survivorship

Odronextamab Plus CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Matthew Matasar, MD

New French Psoriasis Guidelines Add Biologics, Comorbidity Guidance to Algorithm